Rifampin News

Akorn-Strides' rifampin cleared by FDA

Akorn-Strides has announced the approval of an Abbreviated New Drug Application for rifampin for injection USP, 600mg/vial. This is the first lyophilized Injectable product approval for the Joint Venture.

Who Strangled the FDA?

It's possible to read all 300-plus horrifying pages of a new Food and Drug Administration subcommittee report describing the agency's slow asphyxiation by prolonged budgetary constraints without learning who is responsible for...

High dose of old antibiotic offers potent TB treatment

An old antibiotic named Rifapentine has been found to be effective against the most common and contagious form of TB when given in high-doses.

Short-course isoniazid plus rifampin effective for latent TB in children

A three- or four-month regimen of isoniazid plus rifampin is at least as effective as a nine-month course of isoniazid monotherapy in treating latent TB in children, according to results of a prospective, randomized trial.

More drug-resistant TB seen in U.S.

The worst forms of the killer tuberculosis bug have been gaining ground in the United States, alarming public health officials over imported drug-resistant strains of a disease that is mostly under control in this country.

Displaying results 1 to 5 out of 12

1

2

3

Next >

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.